AlphaStocks
5.1
Consider Buy

Vericel Corp (VCEL)

As of Sep 20, 2026, Vericel Corp (VCEL) scores 5.1/10 on AlphaStocks' five-model composite, #105 of 168 Health Care stocks.

Health Care / Biotechnology

S&P SmallCap 600

$40.02

Below average on several measures. Research carefully.

Consider Buy

Score based on 3 of 5 models — moderate confidence

Data as of Sep 20, 2026

#105out of 168 in Health Care

Is Vericel Corp a Good Investment in 2026?

Vericel Corp (VCEL) scores 5.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Vericel Corp as Strong (7/9). However, the Graham model rates it Caution — Significantly above fair value. Vericel Corp ranks #105 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E126.3ROE2.3Market Cap2B

Valuation

Trades at 126x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Vericel Corp (VCEL) a good investment?
As of Sep 20, 2026, Vericel Corp (VCEL) scores 5.1/10 on AlphaStocks' five-model composite, #105 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 126x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.
What is Vericel Corp's Piotroski F-Score?
Vericel Corp's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is VCEL overvalued or undervalued?
A precise fair value estimate is not available for VCEL. Trades at 126x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.
How does VCEL compare to other Health Care stocks?
Vericel Corp ranks #105 out of 168 stocks in the Health Care sector, placing it in the top 62% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about VCEL?
AlphaStocks evaluates VCEL using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Caution. These models are combined into a single composite score of 5.1/10.

Similar Stocks

ABBVINCYHRMY

Compare VCEL with

ABBV vs VCELINCY vs VCELHRMY vs VCELAZN vs VCEL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer